(Q41759490)

8 October 2017

1 reference

title

Advances in the early detection, diagnosis, and staging of pancreatic cancer (English)

1 reference

8 October 2017

1 reference

3

Bartlett DL

1 reference

8 October 2017

2

Libutti SK

1 reference

8 October 2017

Riker A

1

1 reference

8 October 2017

1 November 1997

1 reference

8 October 2017

1 reference

8 October 2017

6

1 reference

8 October 2017

3

1 reference

8 October 2017

157-169

1 reference

Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT.

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

[Spiral scanners: principles and clinical prospects]

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

A comparison of conventional and spiral CT: an experimental study on the detection of spherical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Spiral CT of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Spiral CT and the pre-operative assessment of pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Helical CT evaluation of arterial invasion in pancreatic tumors: comparison with angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Small pancreatic adenocarcinomas: efficacy of MR imaging with fat suppression and gadolinium enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

[Static and dynamic MR tomography of the pancreas: contrast media kinetics of the normal pancreatic parenchyma in pancreatic carcinoma and chronic pancreatitis]

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Normal abdominal enhancement patterns with dynamic gadolinium-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

FDG-PET evaluation of indeterminate pancreatic masses

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Pancreatic neoplasms: how useful is evaluation with US?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

A review of new oncotropic tracers for PET imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Identification and characterization of muscarinic receptors in cultured human pancreatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Staging of pancreatic carcinoma by endoscopic ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Endoscopic ultrasound in pancreatic tumor diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Impact of endoscopic ultrasound with fine-needle aspiration on the surgical management of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Laparoscopic ultrasonography for hepatobiliary and pancreatic malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Early experience of laparoscopic ultrasonography in the management of pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Percutaneous fine-needle aspiration biopsy of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Fine-needle aspiration biopsy of the pancreas: a study of 61 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

A prospective controlled study comparing brush and bile exfoliative cytology for diagnosing bile duct strictures

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

A prospective study of biliary cytology in 100 patients with bile duct strictures

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Cytodiagnosis in the management of extrahepatic biliary stricture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Evaluation of carbohydrate antigens 19-9 and 12-5 in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

A clinical evaluation of monoclonal (CA19-9, CA50, CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the diagnosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Diagnosis of pancreatic cancer and prediction of unresectability using the tumor-associated antigen CA19-9

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Clinical utility of the serum CA 19-9 test for diagnosing pancreatic carcinoma in symptomatic patients: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

CA 19-9 serum course and prognosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Prognostic values of preoperative and postoperative CEA and CA19.9 levels in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

CA 19.9, CA 242 and CEA in the diagnosis and follow-up of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

The Ras signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Ki-ras mutations in chronic pancreatitis: which relevance?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Overexpression of p53 protein in adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2897%2900025-X

7 January 2021

10.1016/S0960-7404(97)00025-X

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9576631